ResearcherUniversité de StrasbourgActive in the last 2 years
Gerlinde Avérous
Matched on ORCID iD 0000-0002-4151-5567; OpenAlex author ID A5084609607. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 22
2017: 3 papers · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper
Papers 7
- Prognostic Impact of type of Arterial Resection on Outcomes of Pancreatectomy with Arterial Resection for Pancreatic Adenocarcinoma. Last author DOI 10.1097/sla.0000000000006779↗
- Splenic vein tumor thrombosis is a major prognostic factor in distal pancreatic adenocarcinoma. Co-author DOI 10.1016/j.surg.2023.10.028↗
- SALL4-related gene signature defines a specific stromal subset of pancreatic ductal adenocarcinoma with poor prognostic features. Co-author DOI 10.1002/1878-0261.13370↗
- Response to the Comment on "Pancreatectomy With Arterial Resection for Pancreatic Adenocarcinoma: How Can It Be Done Safely and With Which Outcomes?" First author DOI 10.1097/sla.0000000000004408↗
- Feasibility and reliability of pancreatic cancer staging using a new confocal non-fluorescent microscopy probe: a double-blind study in rats. Co-author DOI 10.1007/s00464-016-5062-z↗
- Prognostic value of venous invasion in resected T3 pancreatic adenocarcinoma: Depth of invasion matters. Co-author DOI 10.1016/j.surg.2017.03.008↗
- Metabolomics approaches in pancreatic adenocarcinoma: tumor metabolism profiling predicts clinical outcome of patients. Co-author DOI 10.1186/s12916-017-0810-z↗
Closest collaborators
The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Philippe Bachellier · 4 shared papers, 2017–2025 · strength 0.63
- Paper Prognostic Impact of type of Arterial Resection on Outcomes of Pancreatectomy with Arterial Resection for Pancreatic Ad… DOI 10.1097/sla.0000000000006779↗
- Paper Response to the Comment on "Pancreatectomy With Arterial Resection for Pancreatic Adenocarcinoma: How Can It Be Done Sa… DOI 10.1097/sla.0000000000004408↗
- Paper Metabolomics approaches in pancreatic adenocarcinoma: tumor metabolism profiling predicts clinical outcome of patients. DOI 10.1186/s12916-017-0810-z↗
- Pietro Addeo · 3 shared papers, 2017–2025 · strength 0.56
- Paper Prognostic Impact of type of Arterial Resection on Outcomes of Pancreatectomy with Arterial Resection for Pancreatic Ad… DOI 10.1097/sla.0000000000006779↗
- Paper Response to the Comment on "Pancreatectomy With Arterial Resection for Pancreatic Adenocarcinoma: How Can It Be Done Sa… DOI 10.1097/sla.0000000000004408↗
- Paper Prognostic value of venous invasion in resected T3 pancreatic adenocarcinoma: Depth of invasion matters. DOI 10.1016/j.surg.2017.03.008↗
- Patrick Pessaux · 1 shared paper, 2024 · strength 0.18
- Sébastien Gaujoux · 1 shared paper, 2024 · strength 0.18
- Alain Sauvanet · 1 shared paper, 2024 · strength 0.18
- Ugo Marchèse · 1 shared paper, 2024 · strength 0.18
- Mathilde Wagner · 1 shared paper, 2024 · strength 0.18
- António Sá Cunha · 1 shared paper, 2024 · strength 0.18
- Florence Jeune · 1 shared paper, 2024 · strength 0.18
- Jean‐Baptiste Bachet · 1 shared paper, 2024 · strength 0.18
- Angélique Vienot · 1 shared paper, 2023 · strength 0.16
- Christophe Borg · 1 shared paper, 2023 · strength 0.16
- Caroline Truntzer · 1 shared paper, 2023 · strength 0.16
- François Ghiringhelli · 1 shared paper, 2023 · strength 0.16
- S. Battini · 1 shared paper, 2017 · strength 0.07
- Izzie Jacques Namer · 1 shared paper, 2017 · strength 0.07
- Marlène Nguimpi-Tambou · 1 shared paper, 2017 · strength 0.07
- Cherif Youssef Akladios · 1 shared paper, 2017 · strength 0.07
- Jacques Marescaux · 1 shared paper, 2017 · strength 0.07
- Gennaro Nappo · 1 shared paper, 2017 · strength 0.07
- Emanuele Felli · 1 shared paper, 2017 · strength 0.07
- Marc Aprahamian · 1 shared paper, 2017 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.